Literature DB >> 21371207

Viewpoint: Why do we need a point-of-care CD4 test for low-income countries?

R Zachariah1, S D Reid, P Chaillet, M Massaquoi, E J Schouten, A D Harries.   

Abstract

In this paper, we discuss the reasons why we urgently need a point-of-care (POC) CD4 test, elaborate the problems we have experienced with the current technology which hampers CD4-count coverage and highlight the ideal characteristics of a universal CD4 POC test. It is high-time that CD4 technology is simplified and adapted for wider use in low-income countries to change the current paradigm of restricted access once and for all.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21371207     DOI: 10.1111/j.1365-3156.2010.02669.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  34 in total

1.  Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti.

Authors:  Frantz Jean Louis; Anna Janick Osborne; Viala Jean Elias; Josiane Buteau; Jacques Boncy; Angela Elong; Amber Dismer; Vikram Sasi; Jean Wysler Domercant; Daniel Lauture; S Arunmozhi Balajee; Barbara J Marston
Journal:  J AIDS Clin Res       Date:  2015-06-26

Review 2.  Laboratory Innovation Towards Quality Program Sustainability.

Authors:  Alash'le Abimiku; Ralph Timperi; William Blattner
Journal:  Curr HIV/AIDS Rep       Date:  2016-08       Impact factor: 5.071

Review 3.  Emerging technologies for point-of-care CD4 T-lymphocyte counting.

Authors:  David S Boyle; Kenneth R Hawkins; Matthew S Steele; Mitra Singhal; Xuanhong Cheng
Journal:  Trends Biotechnol       Date:  2011-07-26       Impact factor: 19.536

Review 4.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

5.  Performance evaluation of the MBio Diagnostics point-of-care CD4 counter.

Authors:  Cathy Logan; Monique Givens; Jeffrey T Ives; Marie Delaney; Michael J Lochhead; Robert T Schooley; Constance A Benson
Journal:  J Immunol Methods       Date:  2012-10-11       Impact factor: 2.303

6.  Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial.

Authors:  Gideon Amanyire; Fred C Semitala; Jennifer Namusobya; Richard Katuramu; Leatitia Kampiire; Jeanna Wallenta; Edwin Charlebois; Carol Camlin; James Kahn; Wei Chang; David Glidden; Moses Kamya; Diane Havlir; Elvin Geng
Journal:  Lancet HIV       Date:  2016-08-27       Impact factor: 12.767

7.  Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.

Authors:  Muktar H Aliyu; Meridith Blevins; Deidra D Parrish; Karen M Megazzini; Usman I Gebi; Mukhtar Y Muhammad; Mukhtar L Ahmed; Adiba Hassan; Bryan E Shepherd; Sten H Vermund; C William Wester
Journal:  J Acquir Immune Defic Syndr       Date:  2014-02-01       Impact factor: 3.731

8.  Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Authors:  Matilu Mwau; Ferdinard Adungo; Silvia Kadima; Ephantus Njagi; Carolyne Kirwaye; Najma Salim Abubakr; Lucy Atsieno Okubi; Mary Waihenya; Judi Lusike; Jackson Hungu
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

9.  Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification.

Authors:  Livio Azzoni; Andrea S Foulkes; Yan Liu; Xiaohong Li; Margaret Johnson; Collette Smith; Adeeba Bte Kamarulzaman; Julio Montaner; Karam Mounzer; Michael Saag; Pedro Cahn; Carina Cesar; Alejandro Krolewiecki; Ian Sanne; Luis J Montaner
Journal:  PLoS Med       Date:  2012-04-17       Impact factor: 11.069

10.  CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Makhtar Camara; Tandakha Ndiaye Dieye; Souleymane Mboup; Luc Kestens
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.